全髋关节置换术从住院手术名单移除后,CMS机构报销的削减幅度远超实际护理成本的降低幅度
研究对比2015至2019年5271例初次全髋关节置换术(THA)的住院与门诊真实机构成本,发现门诊THA总机构成本降低825美元(95%CI 734-916,P<.001),而CMS因将THA移出住院手术名单平均每例削减报销1637美元,报销削减远超成本节省。
要点
- 门诊THA相比住院THA总机构成本降低825美元(95%CI 734-916,P<.001)。
- CMS将THA移出住院手术名单后平均每例机构报销削减1637美元。
- 报销削减幅度远超门诊THA可实现的每例825美元成本节省。
核心结论
- CMS报销的削减幅度远超机构通过门诊THA可实现的每例825美元成本节省。
- CMS应重新考虑THA的门诊前瞻性支付系统分类,以更好地激励外科医生在安全且适当时将THA作为低成本门诊手术实施。
研究设计与样本
- 研究识别2015年至2019年连续5271例初次全髋关节置换术(THA)病例。
- 使用时间驱动作业成本法算法计算逐项手术成本。
- 门诊手术定义为住院时间不足24小时。
- 比较住院与门诊手术的患者人口学特征、合并症和逐项成本。
- 进行多变量分析以确定门诊状态对真实机构成本的独立影响。
主要发现
- 门诊THA手术783例(14.9%)。
- 门诊THA平均人员成本为1428美元 vs 住院THA 2226美元,P<.001。
- 门诊THA平均耗材成本为4713美元 vs 住院THA 4739美元,P<.001。
- 门诊THA总体机构成本为6141美元 vs 住院THA 6595美元,P<.001。
- 控制混杂变量后,门诊状态与总机构成本降低825美元相关(95%CI 734-916,P<.001)。
关键数值与推荐
- 门诊THA与住院THA相比平均人员成本1428美元 vs 2226美元(P<.001)。
- 门诊THA与住院THA相比平均耗材成本4713美元 vs 4739美元(P<.001)。
- 门诊THA与住院THA相比总体机构成本6141美元 vs 6595美元(P<.001)。
- 控制混杂变量后门诊状态与总机构成本降低825美元相关(95%CI 734-916,P<.001)。
- CMS将THA移出住院手术名单后平均每例机构报销削减1637美元。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Starting in 2020, Centers for Medicare and Medicaid Services (CMS) removed total hip arthroplasty (THA) from the inpatient-only list, resulting in an average of $1637 per case reduction in facility reimbursement. The purpose of this study is to determine whether the reduction in reimbursement is justified by comparing the difference in true facility costs between inpatient and outpatient THA. METHODS: We identified a consecutive series of 5271 primary THA procedures from 2015 to 2019. Itemized procedural costs were calculated using a time-driven activity-based costing algorithm. Outpatient procedures were defined as those with less than a 24-hour length of stay. We compared patient demographics, comorbidities, and itemized costs between inpatient and outpatient procedures. A multivariate analysis was performed to determine the independent effect of outpatient status on true facility costs. RESULTS: There were 783 (14.9%) outpatient THA procedures. The outpatient THA procedures incurred lower mean personnel ($1428 vs $2226, P < .001), supply ($4713 vs $4739, P < .001), and overall facility costs ($6141 vs $6595, P < .001) when compared with the same THA procedures done inpatient. When controlling for confounding variables, outpatient status was associated with a reduction in total facility costs of $825 (95% confidence interval, $734-$916, P < .001). CONCLUSION: The reduction in CMS reimbursement far exceeds the $825 per-patient cost savings that can be achieved by a facility by performing THA as an outpatient. CMS should reconsider the Outpatient Prospective Payment System classification of THA to better incentivize surgeons to perform THA as a lower-cost outpatient procedure when safe and appropriate.
引用
- Lynch JC, Yayac M, Krueger CA, et al. Amount of CMS Reduction in Facility Reimbursement Following Removal of Total Hip Arthroplasty From the Inpatient-Only List Far Exceeds Reduction in Actual Care Cost. J Arthroplasty. 2020. PMID: 32919845. doi:10.1016/j.arth.2020.08.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。